actg036 | R Documentation |
A data set from the AIDS clinical trial ACTG036 (https://clinicaltrials.gov/study/NCT00001104) comparing zidovudine (AZT) with a placebo in patients with hereditary coagulation disorders and HIV infection. The study results were described in Merigan et al. (1991) doi:10.1182/blood.V78.4.900.900. This data set has the same variables as the actg019 data set. We can use the actg019 data as the historical data and the actg036 data as the current data.
actg036
A data frame with 183 rows and 5 variables:
outcome variable with 1 indicating death, development of AIDS or AIDS-related complex (ARC) and 0 otherwise
patient age in years
treatment indicator, 0 = placebo, 1 = AZT
race indicator, 0 = non-white, 1 = white
CD4 cell count
Merigan, T., Amato, D., Balsley, J., Power, M., Price, W., Benoit, S., Perez-Michael, A., Brownstein, A., Kramer, A., and Brettler, D. (1991). Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group. Blood, 78(4), 900–906.
Chen, M.-H., Ibrahim, J. G., and Yiannoutsos, C. (1999). Prior elicitation, Variable Selection and Bayesian computation for Logistic Regression Models. Journal of the Royal Statistical Society Series B: Statistical Methodology, 61(1), 223–242.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.